RhumbLine Advisers’s Precision BioSciences DTIL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.16K | Hold |
275
| – | – | ﹤0.01% | 4029 |
|
|
2025
Q1 | $1.31K | Hold |
275
| – | – | ﹤0.01% | 4011 |
|
|
2024
Q4 | $1.05K | Hold |
275
| – | – | ﹤0.01% | 4075 |
|
|
2024
Q3 | $2.46K | Buy |
+275
| New | +$2.46K | ﹤0.01% | 4049 |
|
|
2022
Q2 | – | Sell |
-1,655
| Closed | -$153K | – | 3136 |
|
|
2022
Q1 | $153K | Buy |
1,655
+73
| +5% | +$6.75K | ﹤0.01% | 2813 |
|
|
2021
Q4 | $351K | Sell |
1,582
-24
| -1% | -$5.33K | ﹤0.01% | 2656 |
|
|
2021
Q3 | $556K | Buy |
1,606
+78
| +5% | +$27K | ﹤0.01% | 2501 |
|
|
2021
Q2 | $574K | Sell |
1,528
-118
| -7% | -$44.3K | ﹤0.01% | 2504 |
|
|
2021
Q1 | $511K | Sell |
1,646
-76
| -4% | -$23.6K | ﹤0.01% | 2481 |
|
|
2020
Q4 | $431K | Buy |
1,722
+160
| +10% | +$40K | ﹤0.01% | 2497 |
|
|
2020
Q3 | $289K | Sell |
1,562
-176
| -10% | -$32.6K | ﹤0.01% | 2535 |
|
|
2020
Q2 | $434K | Buy |
1,738
+502
| +41% | +$125K | ﹤0.01% | 2413 |
|
|
2020
Q1 | $224K | Buy |
1,236
+93
| +8% | +$16.9K | ﹤0.01% | 2536 |
|
|
2019
Q4 | $476K | Buy |
+1,143
| New | +$476K | ﹤0.01% | 2381 |
|